Chronic Salmonella Typhi carriage at sites other than the gallbladder
- PMID: 36952437
- PMCID: PMC10035749
- DOI: 10.1371/journal.pntd.0011168
Chronic Salmonella Typhi carriage at sites other than the gallbladder
Abstract
Typhoid fever caused by infection with Salmonella enterica subspecies enterica serotype Typhi (S. Typhi), an important public health problem in many low- and middle-income countries, is transmitted by ingestion of water or food contaminated by feces or urine from individuals with acute or chronic S. Typhi infection. Most chronic S. Typhi carriers (shedding for ≥12 months) harbor infection in their gallbladder wherein preexisting pathologies, particularly cholelithiasis, provide an environment that fosters persistence. Much less appreciated is the existence of non-gallbladder hepatobiliary chronic S. Typhi carriers and urinary carriers. The former includes parasitic liver flukes as a chronic carriage risk factor. Chronic urinary carriers typically have pathology of their urinary tract, with or without renal or bladder stones. Even as the prevalence of multidrug-resistant and extensively drug-resistant S. Typhi strains is rising, global implementation of highly effective typhoid vaccines is increasing. There is also renewed interest in identifying, monitoring, and (where possible) treating chronic carriers who comprise the long-term reservoir of S. Typhi.
Copyright: © 2023 Hoffman et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
I have read the journal’s policy and the authors of this manuscript have the following competing interests:Dr. MML reports a patent entitled “Broad spectrum vaccine against typhoidal and nontyphoidal Salmonella disease” (US 9,011,871 B2).
Figures
Similar articles
-
Establishment of Chronic Typhoid Infection in a Mouse Carriage Model Involves a Type 2 Immune Shift and T and B Cell Recruitment to the Gallbladder.mBio. 2019 Oct 1;10(5):e02262-19. doi: 10.1128/mBio.02262-19. mBio. 2019. PMID: 31575775 Free PMC article.
-
Diagnostic metabolite biomarkers of chronic typhoid carriage.PLoS Negl Trop Dis. 2018 Jan 26;12(1):e0006215. doi: 10.1371/journal.pntd.0006215. eCollection 2018 Jan. PLoS Negl Trop Dis. 2018. PMID: 29373578 Free PMC article.
-
The frequency and associated factors of typhoid carriage in patients undergoing cholecystectomy for gallbladder disease in Pakistan: A cross-sectional study.PLoS Negl Trop Dis. 2024 Jun 12;18(6):e0011775. doi: 10.1371/journal.pntd.0011775. eCollection 2024 Jun. PLoS Negl Trop Dis. 2024. PMID: 38865361 Free PMC article.
-
Biofilm Producing Salmonella Typhi: Chronic Colonization and Development of Gallbladder Cancer.Int J Mol Sci. 2017 Aug 31;18(9):1887. doi: 10.3390/ijms18091887. Int J Mol Sci. 2017. PMID: 28858232 Free PMC article. Review.
-
The Complex Mechanism of the Salmonella typhi Biofilm Formation That Facilitates Pathogenicity: A Review.Int J Mol Sci. 2022 Jun 9;23(12):6462. doi: 10.3390/ijms23126462. Int J Mol Sci. 2022. PMID: 35742906 Free PMC article. Review.
Cited by
-
Assessing Salmonella Typhi Pathogenicity and Prevention: The Crucial Role of Vaccination in Combating Typhoid Fever.Int J Mol Sci. 2025 Apr 23;26(9):3981. doi: 10.3390/ijms26093981. Int J Mol Sci. 2025. PMID: 40362220 Free PMC article. Review.
-
Typhoid fever.Nat Rev Dis Primers. 2023 Dec 14;9(1):71. doi: 10.1038/s41572-023-00480-z. Nat Rev Dis Primers. 2023. PMID: 38097589 Review.
-
Salmonella Typhi Haplotype 58 (H58) Biofilm Formation and Genetic Variation in Typhoid Fever Patients with Gallstones in an Endemic Setting in Kenya.medRxiv [Preprint]. 2024 Jun 4:2024.06.03.24308409. doi: 10.1101/2024.06.03.24308409. medRxiv. 2024. Update in: Front Cell Infect Microbiol. 2024 Nov 13;14:1468866. doi: 10.3389/fcimb.2024.1468866. PMID: 38883710 Free PMC article. Updated. Preprint.
-
Salmonella Typhi Haplotype 58 biofilm formation and genetic variation in isolates from typhoid fever patients with gallstones in an endemic setting in Kenya.Front Cell Infect Microbiol. 2024 Nov 13;14:1468866. doi: 10.3389/fcimb.2024.1468866. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39606745 Free PMC article.
-
MtlD as a therapeutic target for intestinal and systemic bacterial infections.J Bacteriol. 2025 Jan 31;207(1):e0048024. doi: 10.1128/jb.00480-24. Epub 2024 Dec 27. J Bacteriol. 2025. PMID: 39727397 Free PMC article.
References
-
- Engleberg NC, Barrett TJ, Fisher H, Porter B, Hurtado E, Hughes JM. Identification of a carrier by using Vi enzyme-linked immunosorbent assay serology in an outbreak of typhoid fever on an Indian reservation. J Clin Microbiol. 1983;18(6):1320–1322. Epub 1983/12/01. doi: 10.1128/jcm.18.6.1320-1322.1983 ; PubMed Central PMCID: PMC272900. - DOI - PMC - PubMed
-
- Lin FY, Becke JM, Groves C, Lim BP, Israel E, Becker EF, et al.. Restaurant-associated outbreak of typhoid fever in Maryland: identification of carrier facilitated by measurement of serum Vi antibodies. J Clin Microbiol. 1988;26(6):1194–1197. Epub 1988/06/01. doi: 10.1128/jcm.26.6.1194-1197.1988 ; PubMed Central PMCID: PMC266560. - DOI - PMC - PubMed
-
- Wright PW, Wallace RJ Jr., Steingrube VA, Gibson JL, Barth SS. A case of recurrent typhoid fever in the United States: importance of the grandmother connection and the use of large restriction fragment pattern analysis of genomic DNA for strain comparison. Pediatr Infect Dis J. 1994;13(12):1103–1106. Epub 1994/12/01. . - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources